Combined Tumor-Based
BRCA1/2 tumoral testing
TP53m
allelic frequency
high-grade serous ovarian cancers
loss of heterozygosity
ovarian cancer
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
18 Jul 2023
18 Jul 2023
Historique:
received:
13
03
2023
revised:
26
05
2023
accepted:
03
06
2023
medline:
31
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Somatic/germline
Identifiants
pubmed: 37511329
pii: ijms241411570
doi: 10.3390/ijms241411570
pmc: PMC10380272
pii:
doi:
Substances chimiques
BRCA1 protein, human
0
BRCA1 Protein
0
BRCA2 protein, human
0
BRCA2 Protein
0
TP53 protein, human
0
Tumor Suppressor Protein p53
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
DNA Repair (Amst). 2007 Jul 1;6(7):923-35
pubmed: 17363343
Nat Commun. 2017 Aug 22;8(1):319
pubmed: 28831036
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
N Engl J Med. 2016 Dec;375(22):2154-2164
pubmed: 27717299
Clin Cancer Res. 2014 Feb 1;20(3):764-75
pubmed: 24240112
N Engl J Med. 2012 Apr 12;366(15):1382-92
pubmed: 22452356
N Engl J Med. 2019 Dec 19;381(25):2416-2428
pubmed: 31851799
Nature. 2019 Jul;571(7766):576-579
pubmed: 31292550
Cancer Discov. 2017 Sep;7(9):984-998
pubmed: 28588062
Nat Commun. 2018 Sep 28;9(1):3970
pubmed: 30266954
JNCI Cancer Spectr. 2019 Apr 19;3(2):pkz028
pubmed: 31360904
Oncotarget. 2017 Jul 4;8(27):43653-43661
pubmed: 28525389
PLoS One. 2017 Oct 20;12(10):e0186043
pubmed: 29053726
N Engl J Med. 2019 Dec 19;381(25):2391-2402
pubmed: 31562799
J Clin Oncol. 2019 Nov 10;37(32):2968-2973
pubmed: 31173551
Lancet. 2017 Oct 28;390(10106):1949-1961
pubmed: 28916367
N Engl J Med. 2018 Dec 27;379(26):2495-2505
pubmed: 30345884
Nat Rev Cancer. 2005 Sep;5(9):689-98
pubmed: 16110319